The Barcelona Science Park announces a new artistic intervention competition Blog Post

The Barcelona Science Park (PCB) is holding a new artistic intervention competition which offers participants the chance to design, with total freedom, a 125 metre-long space in the Cluster building, one of the main communication channels between the various research laboratories of the PCB. The ‘L’aigua és vida‘ [Water is life] project, by painter Kelly Arrontes, won the previous competition in 2017.

 

IRB Barcelona has been awarded two ERC Proof of Concept to tackle colon cancer and cardiotoxicity Blog Post

Eduard Batlle and Angel R. Nebreda, ICREA researchers at the Institute for Research in Biomedicine (IRB Barcelona), have been awarded an ERC Proof of Concept grant. Over the next 18 months and supported by 150,000 euros of funding each, they will devote their efforts to developing tools with potential therapeutic applications in the field of oncology. This is the second time that these scientists have received an ERC PoC grant.

 

IBEC joins with Avinent to create prostheses that become real bone Blog Post

Advances in 3D bioprinted prostheses that are truly incorporated into the body –with their own blood vessels and sensitivity– are becoming increasingly more remarkable. This has been demonstrated by Avinent Implant System and the Biomaterials for Regenerative Therapies group led by Elisabeth Engell at the Institute for Bioengineering of Catalonia (IBEC), that are jointly developing an ambitious project to create 3D printed pieces from biomaterials.

 

Dr. Eliandre de Oliveira, cientific leader of the B·Debate on clinical proteomics Blog Post

World leaders in proteomics will meet at CaixaForum Barcelona on 7 and 8 November in an event held by B·Debate, an initiative by Biocat and Obra Social ‘la Caixa’, co-organized in this edition by Barcelona Science Park (PCB), ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Centre for Genomic Regulation (CRG) and Vall d’Hebron Institute of Oncology (VHIO). Four experts of renowned prestige in this field –including Dr. Eliandre de Oliveira, head of the PCB’s Proteomics Platform– will lead the debate.

 

New clues to analyse gene expression through epigenetics Blog Post

Researchers from the Centro Nacional de Análisis Genómico (CNAG-CRG), based in the Barcelona Science Park, and the Institut de Ciències del Mar (ICM-CSIC) have shown that the DNA region known as the first intron, a region to which not much attention had been paid until now, is a key region for analysing gene expression by epigenetic modifications. Anna Esteve-Codina, data analyst of the Functional Genomics team at the CNAG-CRG, is co-author of the paper.

 

SOM Biotech initiates of Phase 2a clinical trial of SOM3355 in Huntington’s disease patients Blog Post

SOM Biotech, a clinical-stage biopharmaceutical company –with headquarters in Barcelona Science Park– that discovers and develops drugs for orphan indications in the central nervous system,  has initiated of Phase 2a clinical trial of its compound SOM3355 for the treatment of the chorea movements associated to Huntington’s disease. The investigational product is a repositioned drug, currently commercialized for the treatment of hypertension. 

 

ilS, five years connecting companies with world experts in health sciences Blog Post

The consultancy firm Insights in Life Sciences (ilS), which is based at the Barcelona Science Park, is celebrating its fifth anniversary this year. With more than 100 projects under its belt, 40 clients and a network of 15,000 experts across the world, the company has consolidated itself as an exceptional liaison between pharma, biotech and medical device companies and life sciences’ Key Opinion Leaders (KOLs), with the aim of helping those Companies make suitable decisions for developing their products or successfully handling licence negotiation processes or funding rounds.

 

Big Data analysis identifies new cancer risk genes Blog Post

Researchers at the Centre for Genomic Regulation (CRG), in collaboration with the Institute for Research in Biomedicine (IRB Barcelona) at PCB, developed a new method to systematically identify genes contributing to heritable cancer risk.The study, published in Nature Communications, is a success story for data sharing and openness in science.